Li4Ti5O12 as anode in all-solid-state, plastic, lithium-ion batteries for low-power applications PP Prosini, R Mancini, L Petrucci, V Contini, P Villano Solid State Ionics 144 (1-2), 185-192, 2001 | 313 | 2001 |
Muir–Torre-like syndrome in Fhit-deficient mice LYY Fong, V Fidanza, N Zanesi, LF Lock, LD Siracusa, R Mancini, ... Proceedings of the National Academy of Sciences 97 (9), 4742-4747, 2000 | 266 | 2000 |
FHIT gene therapy prevents tumor development in Fhit-deficient mice KR Dumon, H Ishii, LYY Fong, N Zanesi, V Fidanza, R Mancini, ... Proceedings of the National Academy of Sciences 98 (6), 3346-3351, 2001 | 217 | 2001 |
The tumor spectrum in FHIT-deficient mice N Zanesi, V Fidanza, LY Fong, R Mancini, T Druck, M Valtieri, T Rüdiger, ... Proceedings of the National Academy of Sciences 98 (18), 10250-10255, 2001 | 208 | 2001 |
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ A Noto, C De Vitis, ME Pisanu, G Roscilli, G Ricci, A Catizone, ... Oncogene 36 (32), 4573-4584, 2017 | 184 | 2017 |
Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells A Noto, S Raffa, C De Vitis, G Roscilli, D Malpicci, P Coluccia, A Di Napoli, ... Cell death & disease 4 (12), e947-e947, 2013 | 166 | 2013 |
Metabolic features of cancer stem cells: the emerging role of lipid metabolism R Mancini, A Noto, ME Pisanu, C De Vitis, M Maugeri-Saccà, G Ciliberto Oncogene 37 (18), 2367-2378, 2018 | 127 | 2018 |
miR-579-3p controls melanoma progression and resistance to target therapy L Fattore, R Mancini, M Acunzo, G Romano, A Laganà, ME Pisanu, ... Proceedings of the National Academy of Sciences 113 (34), E5005-E5013, 2016 | 123 | 2016 |
Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells ME Pisanu, A Noto, C De Vitis, S Morrone, G Scognamiglio, G Botti, ... Cancer letters 406, 93-104, 2017 | 120 | 2017 |
MicroRNAs in melanoma development and resistance to target therapy L Fattore, S Costantini, D Malpicci, CF Ruggiero, PA Ascierto, CM Croce, ... Oncotarget 8 (13), 22262, 2017 | 104 | 2017 |
Age is not the only risk factor in COVID-19: the role of comorbidities and of long staying in residential care homes M D’ascanio, M Innammorato, L Pasquariello, D Pizzirusso, G Guerrieri, ... BMC geriatrics 21, 1-10, 2021 | 97 | 2021 |
The promise of anti-ErbB3 monoclonals as new cancer therapeutics L Aurisicchio, E Marra, G Roscilli, R Mancini, G Ciliberto Oncotarget 3 (8), 744, 2012 | 94 | 2012 |
Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Eμ-TCL1 transgenic mice N Zanesi, R Aqeilan, A Drusco, M Kaou, C Sevignani, S Costinean, ... Cancer research 66 (2), 915-920, 2006 | 90 | 2006 |
Circulating lymphocyte subsets in human acute pancreatitis R Pezzilli, P Billi, E Beltrandi, M Maldini, R Mancini, AMM Labate, ... Pancreas 11 (1), 95-100, 1995 | 89 | 1995 |
SCD1, autophagy and cancer: implications for therapy F Ascenzi, C De Vitis, M Maugeri-Saccà, C Napoli, G Ciliberto, R Mancini Journal of Experimental & Clinical Cancer Research 40 (1), 265, 2021 | 88 | 2021 |
Decreased expression of autophagic beclin 1 protein in idiopathic pulmonary fibrosis fibroblasts A Ricci, E Cherubini, D Scozzi, V Pietrangeli, L Tabbì, S Raffa, L Leone, ... Journal of Cellular Physiology 228 (7), 1516-1524, 2013 | 83 | 2013 |
Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax Expression in Invasive and in Situ Squamous Cell Carcinoma of the Uterine Cervix EGRMTPMAA Vecchione Clinical cancer research 6 (9), 3600-3606, 2000 | 82 | 2000 |
Vorinostat synergizes with EGFR inhibitors in NSCLC cells by increasing ROS via up-regulation of the major mitochondrial porin VDAC1 and modulation of the c-Myc-NRF2-KEAP1 pathway A Leone, MS Roca, C Ciardiello, M Terranova-Barberio, C Vitagliano, ... Free Radical Biology and Medicine 89, 287-299, 2015 | 81 | 2015 |
Investigation into the coupling of micro gas turbines with CSP technology: OMSoP project M Lanchi, M Montecchi, T Crescenzi, D Mele, A Miliozzi, V Russo, ... Energy Procedia 69, 1317-1326, 2015 | 80 | 2015 |
Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters F Licastro, M Chiricolo, E Mocchegiani, N Fabris, M Zannoti, E Beltrandi, ... Journal of Intellectual Disability Research 38 (2), 149-162, 1994 | 80 | 1994 |